Uplizna drug has the main ingredient Inebilizumab-cdon, which is commonly used in the treatment of cases of neuromyelitis optica or neuromyelitis optica spectrum disorders (NMOSD). About the composition, uses, dosage and side effects of Uplizna drug will give patients the best treatment results.

Multiple Sclerosis (MS) is an autoimmune disease that damages the brain and spinal cord. It is characterized by a variety of symptoms, including numbness/weakness in one or more limbs, tremors, dizziness/loss of balance, vision problems such as blurred vision, double vision, partial or complete loss of visual fields, muscle cramps, difficulty speaking, fatigue, depression, and bowel and bladder problems.

Neuromyelitis optica (NMOSD) is a progressive, episodic disease with sensory, motor, visual, and bladder dysfunction that accumulates over time. During an acute attack, symptoms progress over several days and peak, followed by partial recovery over several weeks or months.